GlassScriptPhysician profile
Bruce M Graham
NPI 1598734659
$5,016.35
in general payments reported to CMS, 2019-2025
27 companies · $1,023 in 2025
The $1,023 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.87 · 2020: $16.41 · 2021: $1,423 · 2022: $309 · 2023: $1,677 · 2024: $491 · 2025: $1,023.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,914 · Travel and Lodging: $1,277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.73 |
| Travel and Lodging | $1,277.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,661.99 | 2021-2025 | Watchman Access System, Cds - Mct/Cem Monitoring |
| Medtronic, INC. | $1,353.03 | 2021-2025 | Onyx Frontier, Ffrangio |
| Abbott Laboratories | $543.46 | 2019-2025 | Cardiomems, Aveir, Gallant |
| Janssen Biotech, INC. | $346.69 | 2025 | Tremfya |
| Pfizer INC. | $187.39 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $176.91 | 2024-2025 | |
| Shockwave Medical, INC | $166.74 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $94.60 | 2021-2025 | Lm Undivided |
| Edwards Lifesciences Corporation | $73.66 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.73 | 2025 | Lifevest |
| Abiomed | $43.07 | 2024 | Impella |
| Cardiva Medical, INC. | $42.40 | 2023-2024 | Optowire, Cardiva Vascade 6/7f Vcs |
| Astrazeneca Pharmaceuticals LP | $37.28 | 2022 | |
| Cardiovascular Systems INC. | $36.48 | 2019-2021 | |
| Elutia, INC. | $34.01 | 2022-2024 | Ecm Patch,Pouch |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $32.01 | 2023-2024 | Inpefa |
| Esperion Therapeutics, INC. | $30.35 | 2024-2025 | Nexletol |
| Terumo Medical Corporation | $29.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $21.95 | 2024 | Camzyos |
| Inspire Medical Systems, INC. | $20.40 | 2025 | Inspire |
| Cordis US Corp. | $16.94 | 2024 | Mynx Venous Vcd |
| Cvrx, INC. | $14.71 | 2024 | Barostim Neo System |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.